文献速递神经免疫

多发性硬化中针对特定病毒的鞘内IgG产生的HLA关联

HLA Associations of Intrathecal IgG Production against Specific Viruses in Multiple Sclerosis.
PubMed 文献 · Ann Neurol · 2024-03-29

研究评估184例瑞士多发性硬化(MS)及临床孤立综合征(CIS)患者与89例对照的MRZ反应,并做HLA测序,在176例瑞典MS/CIS患者中重复验证。阳性MRZ反应对MS/CIS高度特异(97.7%),HLA-DRB1*15:01是最强遗传风险因素(瑞士OR 3.90,瑞典OR 2.18),女性阳性概率更高。

要点

  • 阳性MRZ反应在MS/CIS患者中患病率为38.0%,对MS/CIS高度特异(97.7%)。
  • HLA-DRB1*15:01及HLA-DR15单倍型其他紧密连锁等位基因是阳性MRZ反应最强HLA编码风险因素。
  • 女性MS/CIS患者阳性MRZ反应概率显著高于男性(两队列合并,padjusted<0.005)。

核心结论

  • HLA-DRB1*15:01和女性性别使MS/CIS患者易出现阳性MRZ反应,后者是MS最特异的脑脊液生物标志物。

研究设计与样本

  • 评估184例瑞士MS和CIS患者及89例瑞士非MS/非CIS对照患者的MRZ反应,并进行HLA基于测序的分型。
  • 使用176例瑞典MS/CIS患者队列重复验证显著发现。

主要发现

  • 阳性MRZ反应在MS/CIS患者中患病率为38.0%,对MS/CIS高度特异(97.7%)。
  • HLA-DRB1*15:01及其他HLA-DR15单倍型紧密连锁等位基因是瑞士MS/CIS阳性MRZ反应最强HLA编码风险因素(OR 3.90,95%CI 2.05-7.46,padjusted=0.0004)。
  • 瑞典MS/CIS患者中重复验证该发现(OR 2.18,95%CI 1.16-4.02,padjusted=0.028)。
  • 两队列合并,女性MS/CIS患者阳性MRZ反应概率显著高于男性(padjusted<0.005)。

关键数值与推荐

  • 阳性MRZ反应在MS/CIS患者中患病率38.0%。
  • 阳性MRZ反应对MS/CIS的特异性为97.7%。
  • 瑞士MS/CIS中HLA-DRB1*15:01与阳性MRZ反应关联:OR 3.90,95%CI 2.05-7.46,padjusted=0.0004。
  • 瑞典MS/CIS中HLA-DRB1*15:01与阳性MRZ反应关联:OR 2.18,95%CI 1.16-4.02,padjusted=0.028。
  • 两队列合并,女性MS/CIS患者阳性MRZ反应概率显著高于男性(padjusted<0.005)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Specific human leucocyte antigen (HLA) alleles are not only associated with higher risk to develop multiple sclerosis (MS) and other autoimmune diseases, but also with the severity of various viral and bacterial infections. Here, we analyzed the most specific biomarker for MS, that is, the polyspecific intrathecal IgG antibody production against measles, rubella, and varicella zoster virus (MRZ reaction), for possible HLA associations in MS. METHODS: We assessed MRZ reaction from 184 Swiss patients with MS and clinically isolated syndrome (CIS) and 89 Swiss non-MS/non-CIS control patients, and performed HLA sequence-based typing, to check for associations of positive MRZ reaction with the most prevalent HLA alleles. We used a cohort of 176 Swedish MS/CIS patients to replicate significant findings. RESULTS: Whereas positive MRZ reaction showed a prevalence of 38.0% in MS/CIS patients, it was highly specific (97.7%) for MS/CIS. We identified HLA-DRB1*15:01 and other tightly linked alleles of the HLA-DR15 haplotype as the strongest HLA-encoded risk factors for a positive MRZ reaction in Swiss MS/CIS (odds ratio [OR], 3.90, 95% confidence interval [CI] 2.05-7.46, padjusted = 0.0004) and replicated these findings in Swedish MS/CIS patients (OR 2.18, 95%-CI 1.16-4.02, padjusted = 0.028). In addition, female MS/CIS patients had a significantly higher probability for a positive MRZ reaction than male patients in both cohorts combined (padjusted <0.005). INTERPRETATION: HLA-DRB1*15:01, the strongest genetic risk factor for MS, and female sex, 1 of the most prominent demographic risk factors for developing MS, predispose in MS/CIS patients for a positive MRZ reaction, the most specific CSF biomarker for MS. ANN NEUROL 2024;95:1112-1126.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Neidhart S, Vlad B, Hilty M, et al. HLA Associations of Intrathecal IgG Production against Specific Viruses in Multiple Sclerosis. Ann Neurol. 2024. PMID: 38551149. doi:10.1002/ana.26921

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。